Entrada Therapeutics Inc (TRDA)

19.59 +0.36 (+1.87%) USD  |  NASDAQ  |  Nov 08, 13:10
More

Entrada Therapeutics Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for TRDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to 2023. Upgrade now.
Date Value
December 31, 2023 --

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

Upgrade
Minimum
2023
Upgrade
Maximum
2023
Upgrade
Average
Upgrade
Median
2023

Research and Development Expense (% of Annual Revenues) Benchmarks

Fulcrum Therapeutics Inc Upgrade
Sarepta Therapeutics Inc Upgrade
Catalyst Pharmaceuticals Inc Upgrade
Vertex Pharmaceuticals Inc Upgrade
Regenxbio Inc Upgrade